tiprankstipranks
Trending News
More News >
Design Therapeutics (DSGN)
NASDAQ:DSGN
US Market
Advertisement

Design Therapeutics (DSGN) Ownership - Who Owns Design Therapeutics?

Compare
93 Followers

Design Therapeutics (DSGN) Ownership Overview

18.53%6.87%37.98%5.46%31.15%
18.53% Insiders
37.98% Other Institutional Investors
5.46% ETFs
31.15% Public Companies and
Individual Investors
The ownership structure of Design Therapeutics (DSGN) stock is a mix of institutional, retail, and individual investors. Approximately 50.32% of the company’s stock is owned by Institutional Investors, 18.53% is owned by Insiders, and 31.15% is owned by Public Companies and Individual Investors.
The ownership structure of Design Therapeutics (DSGN) stock is a mix of institutional, retail, and individual investors. Approximately 44.86% of the company’s stock is owned by Institutional Investors, 18.53% is owned by Insiders, and 5.46% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 14, 2025
xxxxxxxxxxxxx
$2953792
Dec 19, 2024
xxxxxxxxxxxxx
$23864

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2025
xxxxxxxxxxxxx
$2620299
Jun 30, 2025
xxxxxxxxxxxxx
$3626915
Jun 30, 2025
xxxxxxxxxxxxx
$5772412

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
6,526,476Insider11.46%38,245,149
3,655,000Insider6.42%21,418,300
1,712,882Institution3.01%10,037,489
1,341,073Institution2.35%7,858,688
1,254,251Institution2.20%7,349,911
1,227,169Institution2.15%7,191,210
1,076,236Institution1.89%6,306,743
839,131Institution1.47%4,917,308
777,537Institution1.37%4,556,367
356,571Institution0.63%2,089,506

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,227,169Institution2.15%7,191,210
839,131Institution1.47%4,917,308
356,571Institution0.63%2,089,506
277,377Institution0.49%1,625,429
264,662Institution0.46%1,550,919
179,700Institution0.32%1,053,042
179,629Institution0.32%1,052,626
104,423Institution0.18%611,919
95,332Institution0.17%558,646
86,711Institution0.15%508,126

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
783,620Institution1.38%3,032,609
758,698Institution1.33%4,438,383
295,050Institution0.52%1,141,844
264,273Institution0.46%1,545,997
181,875Institution0.32%1,063,969
152,803Institution0.27%591,348
136,530Institution0.24%800,066
86,584Institution0.15%522,102
75,024Institution0.13%438,890
63,023Institution0.11%369,315

FAQ

Who Owns Design Therapeutics (DSGN)?
According to the latest TipRanks data, approximately 37.98% of the company's stock is held by institutional investors, 18.53% is held by insiders, and 31.15% is held by retail investors.
    What percentage of Design Therapeutics (DSGN) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 37.98% of Design Therapeutics (DSGN) stock is held by institutional investors.
      What percentage of Design Therapeutics (DSGN) stock is held by retail investors?
      According to the latest TipRanks data, approximately 31.15% of Design Therapeutics (DSGN) stock is held by retail investors.
        Who owns the most shares of Design Therapeutics (DSGN)?
        Simeon George owns the most shares of Design Therapeutics (DSGN).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis